Taro Pharmaceutical Industries Shares Approach 52-Week Low - Market Mover
The shares closed 1.7% above its 52-week low of $46.81, with trading volume lower than its 30 day average
Dec 30, 2021 by Kwhen Finance Editors
Taro Pharmaceutical Industries (TARO) shares closed today at 1.7% above its 52 week low of $46.81, giving the company a market cap of $1B. The stock is currently down 31.7% year-to-date, down 30.3% over the past 12 months, and down 45.4% over the past five years. This week, the Dow Jones Industrial Average rose 2.1%, and the S&P 500 rose 2.1%.
Trading Activity
- Trading volume this week was 79.5% higher than the 20-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 0.5.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was between 30 and 70.
- MACD, a trend-following momentum indicator, indicates an upward trend.
- The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
- The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis
Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
---|---|---|---|---|---|
Taro Pharmaceutical Industries | 4.5 | -31.7 | -30.3 | -38.3 | 5.4 |
Dow Jones Industrial Average | 0.2 | 21.3 | 22.3 | 0.0 | 24.5 |
S&P 500 Index | 0.1 | 29.4 | 30.3 | -0.2 | 32.8 |
Health Care | 0.6 | 23.7 | 25.0 | -0.9 | 26.8 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by -326.5%
- The company's stock price performance over the past 12 months lags the peer average by -308.8%
Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
---|---|---|---|---|---|---|
Taro Pharmaceutical Industries | TARO | 0 | -31.7 | -30.3 | -38.3 | 5.4 |
Peer Avg | N/A | 22.7 | 14.0 | 14.5 | -11.6 | 94.0 |
Johnson & Johnson | JNJ | 25.3 | 11.8 | 14.1 | -3.2 | 15.8 |
Pfizer Inc. | PFE | 16.9 | 62.5 | 61.5 | -6.8 | 77.2 |
Novartis AG - ADR | NVS | 37.2 | -2.9 | -1.8 | -7.6 | 10.8 |
Merck & Co Inc | MRK | 27.0 | -2.5 | -2.1 | -15.3 | 414.6 |
Glaxosmithkline plc - ADR | GSK | 17.2 | 27.7 | 27.1 | -0.1 | 37.8 |
Teva- Pharmaceutical Industries Ltd. - ADR | TEVA | 12.8 | -12.6 | -11.7 | -36.8 | 8.1 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: